BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DNA fingerprint
,
Lovastatin
,
rs6983267
,
NEUROG3
,
T cell differentiation
,
Lung cancer
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pirarubicin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Diffuse large B cell lymphomas from brains of primary CNS lymphoma patients
Explore Curated Studies Results
Literature
Most Relevant Literature
LncRNA Miat knockdown enhances pirarubicin-mediated anticancer sensitivity in breast cancer cells.
The application of gemcitabine and pirarubicin in patients with non-muscle invasive bladder cancer.
Food therapy of scutellarein ameliorates pirarubicin‑induced cardiotoxicity in rats by inhibiting ap…
Development and evaluation of PLA based hybrid block copolymeric nanoparticles for systemic delivery…
An in situ forming gel co-loaded with pirarubicin and celecoxib inhibits postoperative recurrence an…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Pegylated Liposomal Doxorubicin Versus Pirarubicin Plus Ifosfamide, Dacarbazine in Locally Advanced,…
Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combin…
Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer
CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T …
Adjuvant Chemotherapy for Triple Negative Breast Cancer Patients With Residual Disease After Neoadju…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ